Here’s whether Cardinal Health, Inc. (CAH) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Caution.
🟡
Caution
Positives: trading above the 200-day MA (long-term uptrend intact); strong 1-year return of +34.2%. Concerns: below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-1.96% over 10 days); 3-month momentum negative (-10.8%). Currently 16.4% off its 52-week high. Score: +0/7.
CAH is holding above its long-term 200-day MA ($189.29) but has slipped below the 50-day MA ($213.39), pointing to short-term weakness in an otherwise intact trend. An RSI of 30.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +34.2% compares to +27.9% for SPY (beat the market by 6.3%).
$10,000 invested 1 year ago→ $13,416 today
vs. S&P 500 (SPY) — same period beat market by 6.3%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($189.29)
✗Above 50-day MA ($213.39)
✓RSI(14) neutral zone (30–70) — currently 30.8
✓Positive return (+34.2%)
!Within 10% of period high (−16.4%)
Period Range $195.24
$136.71$233.60
RSI (14) 30.8
0 · OversoldOverbought · 100
Key Metrics
Price$195.24
Period Return+34.2%
Period High$233.60
Period Low$136.71
Drawdown−16.4%
MA-50$213.39
MA-200$189.29
RSI (14)30.8
Avg Volume (30d)1.8M
vs. SPYbeat by 5.1%
Return Rank#471 of 1236
Trend Signals
Price is above the 200-day moving average ($189.29)
Price is below the 50-day moving average ($213.39)